Any Gene to Any Cell
SIRION Biotech designs and manufactures viral vectors for cell and gene therapy research and preclinical development. We have active R&D in the areas of AAV and LV vector optimization focused on clinically compliant vector designs, plus upstream and downstream process development for AAV, AV, and Lentivirus manufacture.
GENE THERAPY
AAV
CELL THERAPY
Lentivirus
VACCINATION
Adenovirus
You have questions or need support? Contact us
Viral Vector Engineering and Manufacturing
Multilingual Consulting
Broad Element Portfolio
Precise Time Management
Highest Quality Standards
R&D Partnership for New Technologies and IP
With 2000+ projects for 150+ repeat clients in Cancer Research, Neurosciences, Regenerative Medicines,
Gene Therapy, CAR-T Cell Development & Vaccine Development, SIRION Biotech understands the technical challenges of viral vector engineering and manufacturing.
SIRION Biotech develops optimized viral vectors for gene and cell therapy, and vaccine development. We offer one of the world’s most comprehensive viral vector technology platforms based on lentiviruses, adenoviruses, and adeno-associated viruses (AAV). SIRIONs custom engineering and manufacturing expertise advance gene and cell therapy research and drug development.